CB Insights
Technology Market Intelligence
Technology Market Intelligence
EffRx Pharmaceuticals exploits drug delivery technologies to improve the efficacy and tolerability of existing approved compounds with a focus on drugs, with high commercial potential. Once developed, the company partners these products with establis...Show all
Company (Alive / Active)
Phone: +41 44 503 78 60
Wolleraustrasse 41B
Freienbach, CH-8807
Switzerland
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|---|---|---|
| Undisclosed Investors | Other | Unattributed | |
| Seventh Framework Programme | Government | United Kingdom | Grant |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Stable effervescent bisphosphonate formulations with rapid solubilization characteristics | Dec 05, 2011 | Mar 14, 2017 | Patent |
| Effervescent compositions comprising phosphonates and methods related thereto | May 02, 2011 | May 28, 2013 | Patent |
| Low-sodium effervescent pharmaceutical formulations | Mar 01, 2014 | Application |
